575 results about "Blood testing" patented technology

The present invention is a programmable, automated device for the measurement and analysis of blood analytes and blood parameters. The device components are combined in a single apparatus and either programmed to initiate automatic, periodic blood sampling or initiate automatic blood sampling via operator input. The device operates automatically to draw blood samples at suitable, programmable frequencies to analyze the drawn blood samples and obtain the desired blood readings.

The invention provides a system for monitoring a patient that includes: 1) a first database that stores the patient's blood test information; 2) a monitoring device that collects the patient's cardiovascular and exercise information; 3) a second database that receives cardiovascular and exercise information from the monitoring device; and 4) an Internet-based system that displays the blood test, cardiovascular, and exercise information.

A blood sensor comprises a base (12), a detection part (16) disposed on the base (12), a blood collection needle (13) disposed at a front end (12a) of the base (12), a negative pressure generation part (17) for applying negative pressure to a portion of the blood collection needle (13), and a supply path (15) for supplying blood collected by the blood collection needle (13) to a detection part (16).

The present invention is a programmable, automated device for measurement and analysis of blood analytes and blood parameters. The device components are preferably combined in a single housing and either programmed to initiate automatic, periodic blood sampling or initiate automatic blood sampling via operator input or in response to a predefined event or in response to a signal from another instrument. The device operates automatically to draw blood samples and analyze the drawn blood samples to obtain the desired blood readings.

Devices and methods for performing a point of care blood, cell, and / or pathogen count or a similar blood test. Disclosed herein are systems that can be used to provide rapid, accurate, affordable laboratory-quality testing at the point of care. The systems described herein are capable of imaging and counting individual cells in a prepared cell sample (e.g., a peripheral blood smear or a blood sample prepared in a microfluidic device) or another prepared cell-containing sample without the need for a microscope or other expensive and cumbersome optics. The systems described herein are designed to eliminate or replace expensive, centralized clinical testing equipment and technical personnel. Such systems may include automated data reporting and decision support.

The disclosed inventions provide for improvements to data storage that is integral to sample containers such as test tubes. Systems and methods for enclosing radio frequency read / writeable chips within sample containers are described, as well as systems and methods for gathering data to be stored. Examples of useful medical contexts for the technology are presented, including for physician and lab blood testing data. Some embodiments disclose systems and methods that can track data and process samples with the help of a portable unit. Some embodiments of the portable units not only assist in entering, storing, and transmitting medical data, they also comprise novel systems that can process and or analyze whole blood. Accordingly, centrifuge portions are described, including two novel types of test tube valves that function in concert with the described centrifuge portions.

A Cardiovascular imaging and functional analysis system and method employing a dedicated fast, sensitive, compact and economical imaging gamma camera system that is especially suited for heart imaging and functional analysis. The system uses a dedicated nuclear cardiology small field of view imaging camera, allowing image physiology, while offering inexpensive and portable hardware. In some variations, a basic modular design suitable for cardiac imaging with one of several radionucleide tracers is used. The detector is positioned in close proximity to the chest and heart from several different projections, allowing rapid accumulation of data for first-pass analysis, positron imaging, quantitative stress perfusion, and multi-gated equilibrium pooled blood tests. In one variation, a Cardiovascular Non-Invasive Screening Probe system provides rapid, inexpensive preliminary indication of coronary occlusive disease by measuring the activity of emitted particles from an injected bolus of radioactive tracer.

The present invention is a system and a method for blood or urine sampling and sample-analysis, through a sampler that is a self blood-testing device or a urine-testing device. The system comprises a sampler, a transmission unit and an analysis unit. A patient may place a sampled blood drops on a sample strip and insert the strip into the sampler. The sampler may automatically prepare the sample and photograph it using a sample-preparation unit and a photography unit respectively. After the sample has been photographed, the resulting sample image may be transmitted to the analysis unit that may analyze the image through an image-processing algorithm. The analysis results may be automatically transmitted to the patient and to a medical authority, such as the patient's physician, a nurse, a clinic and the like, for further analysis, decision-making and treatment.

The present invention relates to methods and systems for providing an animal with a nutraceutical program that is specifically tailored to address the deficiencies and / or needs of the particular animal. Blood is drawn from the animal and analyzed at a lab to obtain blood test results. The blood test results are scored to obtain at least one blood test score for at least one corresponding blood parameter. If the at least one blood test score falls within a normal range but outside of an optimal range, one or more nutraceuticals needed to bring the animal within the optimal range for the at least one corresponding blood parameter are identified. A prescribed dosage amount is then calculated for at least one of the one or more identified nutraceuticals for the animal. The calculation of the prescribed dosage amount is based on at least the blood test score for the corresponding blood parameter and a deviation of the blood test score from the optimal range.

It is intended to provide a blood test apparatus whereby the vicinity of a site to be punctured for collecting the blood can be negatively pressurized and the negative pressurization can be conducted at an appropriate time without resorting to a special operation, thereby facilitating a blood test. More specifically speaking, a blood test apparatus which comprises: a housing having an opening: a puncture means located in the opening; a first sensing means whereby the contact of the front face of the opening with a site to be punctured is detected; a negative pressurization means whereby the inside of the opening is negatively pressurized; a blood sensor whereby the blood, that flows out from the punctured site having been punctured by the puncture means after negatively pressurizing the inside of the opening by the negative pressurization means, is collected; and a measurement circuit whereby a signal obtained from the blood sensor analyzing components in the blood is measured, wherein the negative pressurization means starts up when the first sensing means detects the contact of the front face of the opening with the site to be punctured.

Methods and devices for isolating and diagnosing disease with a cell adhesion matrix system, mimicking a metastatic, cardiovascular or placental environment, are disclosed. The cell adhesion matrix facilitates the enrichment of target cells such as metastatic tumor cells, fetal cells and endothelial progenitor cells from a fluid sample such as blood for diagnostic and therapeutic applications in treating patients afflicted with disease, such as cancerous, cardiovascular and fetal diseases, as well as for research applications in molecular analysis of metastatic, and cardiovascular and fetal diseases. Blood test prototypes and methods for the cell enrichment and detection of circulating tumor and endothelial cells using multiplex molecular analysis are described herein. In addition, methods and compositions for determining host immunity to tumor in subjects with risk of cancer progression and methods for isolating an enriched fraction of fetal cells from pregnant females for prenatal diagnosis are also described herein.

Amplification and overexpression of theHER-2 oncogene in breast cancer is felt to be stable over the course of disease and concordant between the primary tumor and metastases. Therefore, patients with HER-2 negative primary tumors will rarely receive anti-HER-2 antibody therapy. A very sensitive blood test is used to capture circulating tumor cells (CTC's) and evaluate their HER-2 gene status by FISH evaluation. The HER-2 status of the primary tumor and corresponding CTC's is used to assess the ratio of CTC's as a reliable surrogate marker. HER-2 expression of 10 CTC's is sufficient to make a definitive diagnosis of the HER-2 gene status for the whole population of CTC's in patients with recurrent breast cancer.

A system and method for determining a coagulation time, e.g., TT, PT, aPTT, and ACT, of a blood test sample deposited in a test cartridge is disclosed. A cartridge housing having upper and lower major sides and a minor sidewall encloses a test chamber having a test chamber pivot element and is provided with a cartridge port for introducing a test sample into the test chamber,. Ferromagnetic agitator vane leaflets extend from an agitator pivot element supported by the test chamber pivot element intermediate the upper and lower major sides for rotational motion. The agitator vane leaflets can be swept, in response to an external magnetic field, through the test sample in the absence of coagulation. A timer is started when the agitator movement is commenced whereupon the agitator moves freely. Resistance to agitator movement due to coagulation is detected, and the coagulation time is measured.

The present invention is a Miniature Vein Enhancer that includes a Miniature Projection Head. The Miniature Projection Head may be operated in one of three modes, AFM, DBM, and RTM. The Miniature Projection Head of the present invention projects an image of the veins of a patient, which aids the practitioner in pinpointing a vein for an intravenous drip, blood test, and the like. The Miniature projection head may have a cavity for a power source or it may have a power source located in a body portion of the Miniature Vein Enhancer. The Miniature Vein Enhancer may be attached to one of several improved needle protectors, or the Miniature Vein Enhancer may be attached to a body similar to a flashlight for hand held use. The Miniature Vein Enhancer of the present invention may also be attached to a magnifying glass, a flat panel display, and the like.

A method and a system for using RFID (Radio Frequency Identification) in the workflow of a blood center and a medical institution from a network Customer Relationship Management (CRM) information system. The CRM comprises an RFID technique system, a computer database system, and a computer information network. The information transferred between an integrated circuit and a reader-writer occurs through the radio waves in the workflow of, for example, a blood center or other medical institution. The related information ranges from identity information to biological product information. In each procedure of the blood collecting and supply workflow, the information is read / written by the computer into electronic tag and through the computer information network into the service management information system. The work flow of blood centers (stations), such as blood test reports before and after blood transfusions and the desired information of people and objects involved in blood transfusions, can thereby be recorded completely, integrally, precisely, and comprehensively by the RFID system.

A blood testing tool is provided, which separates blood cells and can collect blood plasma or blood serum with a high yield. The blood testing tool includes an asymmetric porous membrane with a pore size distribution in which an average pore size varies to be reduced continuously or discontinuously in a thickness direction. The porous membrane includes a blood supply portion, a development portion, and a blood-cell blocking portion formed between the blood supply portion and the development portion and pores in the blood cell blocking portion include only pores through which blood cells cannot pass. When blood is supplied to one side with larger pores of the blood supply portion, the blood moves in a direction parallel to a surface of the porous membrane by a capillary phenomenon, but only blood plasma or blood serum moves into the development portion to develop.

A system and method are provided for determining intravenous blood levels of a target compound contained in a blood vessel of a patient. The method includes the operation of detecting concentrations of the target compound within a patient's blood using a sensor device configured to optically test blood at a location within the blood vessel. Another operation is calculating a measured amount of a therapeutic compound to administer into the patient's bloodstream based on the concentrations of the target compound in the blood. The measured amount of therapeutic compound may then be pumped through the catheter into the patient's blood.

The present invention is a Miniature Vein Enhancer that includes a Miniature Projection Head. The Miniature Projection Head may be operated in one of three modes, AFM, DBM, and RTM. The Miniature Projection Head of the present invention projects an image of the veins of a patient, which aids the practitioner in pinpointing a vein for an intravenous drip, blood test, and the like. The Miniature projection head may have a cavity for a power source or it may have a power source located in a body portion of the Miniature Vein Enhancer. The Miniature Vein Enhancer may be attached to one of several improved needle protectors, or the Miniature Vein Enhancer may be attached to a body similar to a flashlight for hand held use. The Miniature Vein Enhancer of the present invention may also be attached to a magnifying glass, a flat panel display, and the like.

A connector to receive blood test chips for use with a blood-substance measuring device includes a receptacle, a plug and a wire lead. The receptacle has two ends and a slot. The slot is formed on one end of the receptacle and receives a test chip. The wire lead connects to the other end of the receptacle and the plug. The plug is adapted to be inserted into a corresponding socket in the blood-substance measuring device to electrically connect the test chip to the device.

An image interpretation report creating apparatus for displaying a case in combination of an image interpretation report and a blood test result even if they are stored in different computers. The apparatus includes: a display unit for displaying an image interpretation report creation screen along with a blood test result; an input unit for specifying finding and a blood test result; a search key generating unit for generating search keys for searching an image interpretation report DB and a blood test result DB; a search processing unit for causing an image interpretation report server and an examination result server to obtain cases that match the search keys; a similarity degree determining unit for displaying the cases in an order of the degree of similarity; and an image interpretation report preservation unit for causing the image interpretation report server to store image interpretation report data.

A blood test device (21) ensuring successful measurement wherein fingers scarcely slip out from the blood test device and blood never sticks to other sites in the course from the puncture of the patient's skin to the completion of the blood test. This blood test device (21) comprises a cartridge (24) in which sensors (23) pooling blood oozing out from the punctured skin are stored in a layered state, a transport unit transporting a single sensor sheet (23) from the inside of the cartridge (24) to the outside, a holder (25) holding the transported sensor (23), a laser emitting unit (26) puncturing the skin in the state where the sensor (23) is held by the holder (25), and a pump (28) keeping the inside of the holder (25) and the inside of the cartridge (24) under negative pressure.